Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.33 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyclopropane SCHEMBL17923269 | 1.00 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNATP53CA1 | |
| SCHEMBL13324558 | 0.92 | TSHR (0.47) | ALDH1A1TSHRLMNATP53CA1 | |
| SCHEMBL8832603 | 0.92 | TSHR (0.47) | ALDH1A1TSHRLMNATP53CA1 | |
| SCHEMBL20278839 | 0.92 | TSHR (0.47) | ALDH1A1TSHRLMNATP53CA1 | |
| SCHEMBL15066 | 0.92 | — | — | |
| SCHEMBL9439689 | 0.92 | TSHR (0.47) | ALDH1A1TSHRLMNATP53CA1 | |
| SCHEMBL14717601 | 0.88 | — | — | |
| SCHEMBL8984959 | 0.88 | — | — | |
| SCHEMBL8984924 | 0.88 | — | — | |
| Bicarbonate SCHEMBL7919698 | 0.87 | ALDH1A1 (0.33) | ALDH1A1TSHRLMNATP53CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0814848-B1 | MICROPARTICLES, AGENTS CONTAINING SAID MICROPARTICLES FOR USE IN ULTRASOUND DIAGNOSTICS, AND PROCESSES FOR PRODUCING SAID PARTICLES AND AGENTS | ACTIPAC BIOSYSTEMS GMBH (DE) | 2002-12-18 | — | — | EP | claimed |
| CN-109414331-A | With the management biodegradable medical implant of formula | 聚合-医药有限公司 | 2019-03-01 | — | — | CN | disclosed |
| US-6207135-B1 | BIODEGRADABLE WALL MATERIAL OF THE PARTICLES IS MADE FROM A BLEND OF LIQUID CRYSTALS BLOCK POLYMERS OF POLYLACTONES AND POLYOXYETHYLENE GLYCOL OR POLYLACTONES; CONTROLLED RETENTION TIME; CONTRAST OF BLOOD FLOW, ORGANS; NONTOXIC; ANTIALLERGENS | INHALE THERAPEUTIC SYSTEMS, INC. | 2001-03-27 | — | — | US | disclosed |